EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access

A Factorial Randomized Clinical Trial of Nicotine Replacement Therapy and Treatment Recommendations to Quit Versus Continue E-cigarettes When Quitting Smoking in Young Adult Dual Users

Elias M Klemperer iD, Marc Jerome P Feinstein, Katya Marsh, Andrea C Villanti iD, Matthew J Carpenter iD, Joan M Skelly, Michael J DeSarno, Stephen T Higgins

Nicotine and Tobacco Research · 2025

DOI: 10.1093/ntr/ntaf119 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Nicotine and Tobacco Research, 2025. Verfasst von Elias M Klemperer und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, College of Medicine, University of Vermont, Burlington, VT, USA. Hauptthemen laut MEDLINE: Smoking Cessation, Electronic Nicotine Delivery Systems, Tobacco Use Cessation Devices. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, NIDA NIH HHS, NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Multiple tobacco product use has increased markedly in the United States, especially dual use of cigarettes and e-cigarettes among young adults. Little is known regarding nicotine replacement therapy (NRT) for young adult dual users, or whether to recommend quitting versus continuing e-cigarettes during smoking cessation treatment.

Methods

This 2 × 2 factorial trial randomized 396 young adult dual users (aged 18–29; ≥ 5 cigarettes/day; used e-cigarettes on ≥ 10 of past 30 days) to receive 12 weeks of combination NRT versus No NRT to quit smoking, plus text-based treatment recommendations to Quit versus Continue E-cigarettes. The primary outcome was self-reported end-of-treatment 7-day point-prevalence abstinence (PPA) from cigarettes; a secondary outcome was end-of-treatment 30-day PPA from cigarettes.

Results

Participants were 26.0 (SD = 6.8) years old, 52.8% female, and 26.5% non-white. At week 12, NRT increased 7-day PPA (NRT = 50.5% versus No NRT = 39.9%; OR = 1.54, 95% CI = 1.03, 2.29), but neither treatment recommendation (Quit E-cigarettes = 48.0% versus Continue E-cigarettes = 42.4%; OR = 1.25, 95% CI = 0.84, 1.85) nor the NRT-by-treatment recommendation interaction were significant. The direction and magnitude of main effects for 30-day PPA at week 12 were similar to 7-day PPA, but the NRT-by-treatment recommendation interaction was significant (p = .04): smoking cessation was greatest for the NRT plus Quit E-cigarettes condition (47.1%) versus NRT plus Continue E-cigarettes (28.1%); No NRT plus Quit E-cigarettes (29.2%); and No NRT plus Continue E-cigarettes (30.4%) conditions (all p < .05).

Conclusions

NRT is effective in promoting early smoking cessation among young adult dual users. Secondary findings indicate that pairing NRT with support to quit both products could enhance the effects on prolonged cigarette abstinence.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Smoking CessationElectronic Nicotine Delivery SystemsTobacco Use Cessation DevicesHumansFemaleMaleAdultYoung AdultAdolescentTreatment OutcomeNicotine Replacement Therapy

Autor:innen und Institutionen

  • Department of Psychiatry, College of Medicine, University of Vermont, Burlington, VT, USA.
  • Department of Psychological Science, College of Arts and Sciences, University of Vermont, Burlington, VT, USA.
  • Rutgers Institute for Nicotine & Tobacco Studies Rutgers Health, Department of Health Behavior, Society & Policy, Rutgers School of Public Health, New Brunswick, NJ, USA.
  • Department of Psychiatry & Behavioral Sciences, Hollings Cancer Center, Medical University of South Carolina, Charleston, SC, USA.
  • Department of Biostatistics, University of Vermont, Burlington, VT, USA.

ORCID-Profile: Elias M Klemperer, Andrea C Villanti, Matthew J Carpenter

Förderung

  • NIGMS NIH HHS
  • NIDA NIH HHS
  • NCI NIH HHS
  • National Institute of General Medical Sciences
  • U.S. Food and Drug Administration
  • National Institute on Drug Abuse
  • National Cancer Institute

Zitieren

APA

Klemperer, E. M., Feinstein, M. J. P., Marsh, K., Villanti, A. C., Carpenter, M. J., Skelly, J. M., DeSarno, M. J., & Higgins, S. T. (2025). A Factorial Randomized Clinical Trial of Nicotine Replacement Therapy and Treatment Recommendations to Quit Versus Continue E-cigarettes When Quitting Smoking in Young Adult Dual Users. Nicotine and Tobacco Research. https://doi.org/10.1093/ntr/ntaf119

Vancouver

Klemperer EM, Feinstein MJP, Marsh K, Villanti AC, Carpenter MJ, Skelly JM, et al. A Factorial Randomized Clinical Trial of Nicotine Replacement Therapy and Treatment Recommendations to Quit Versus Continue E-cigarettes When Quitting Smoking in Young Adult Dual Users. Nicotine and Tobacco Research. 2025. doi:10.1093/ntr/ntaf119

BibTeX
@article{Klemperer2025,
  author = {Klemperer, Elias M and Feinstein, Marc Jerome P and Marsh, Katya and Villanti, Andrea C and Carpenter, Matthew J and Skelly, Joan M and DeSarno, Michael J and Higgins, Stephen T},
  title = {A Factorial Randomized Clinical Trial of Nicotine Replacement Therapy and Treatment Recommendations to Quit Versus Continue E-cigarettes When Quitting Smoking in Young Adult Dual Users},
  journal = {Nicotine and Tobacco Research},
  year = {2025},
  doi = {10.1093/ntr/ntaf119}
}
Kostenlos starten →